192 related articles for article (PubMed ID: 25695339)
1. The inflammatory marker suPAR after cardiac arrest.
Rundgren M; Lyngbaek S; Fisker H; Friberg H
Ther Hypothermia Temp Manag; 2015 Jun; 5(2):89-94. PubMed ID: 25695339
[TBL] [Abstract][Full Text] [Related]
2. The predictive value of soluble urokinase plasminogen activator receptor (SuPAR) regarding 90-day mortality and 12-month neurological outcome in critically ill patients after out-of-hospital cardiac arrest. Data from the prospective FINNRESUSCI study.
Jalkanen V; Vaahersalo J; Pettilä V; Kurola J; Varpula T; Tiainen M; Huhtala H; Alaspää A; Hovilehto S; Kiviniemi O; Kuitunen A; Tenhunen J;
Resuscitation; 2014 Nov; 85(11):1562-7. PubMed ID: 25193800
[TBL] [Abstract][Full Text] [Related]
3. The significance of serum urokinase plasminogen activation receptor (suPAR) in the diagnosis and follow-up of febrile neutropenic patients with hematologic malignancies.
Kaya S; Köksal I; Menteşe A; Sönmez M; Sümer A; Yıldırım SS; Yılmaz G
Int J Infect Dis; 2013 Nov; 17(11):e1056-9. PubMed ID: 23742830
[TBL] [Abstract][Full Text] [Related]
4. Use of S-100B, NSE, CRP and ESR to predict neurological outcomes in patients with return of spontaneous circulation and treated with hypothermia.
Choi S; Park K; Ryu S; Kang T; Kim H; Cho S; Oh S
Emerg Med J; 2016 Oct; 33(10):690-5. PubMed ID: 27287003
[TBL] [Abstract][Full Text] [Related]
5. Soluble urokinase plasminogen activator receptor in plasma is associated with incidence of CVD. Results from the Malmö Diet and Cancer Study.
Persson M; Engström G; Björkbacka H; Hedblad B
Atherosclerosis; 2012 Feb; 220(2):502-5. PubMed ID: 22119508
[TBL] [Abstract][Full Text] [Related]
6. Soluble urokinase plasminogen activator receptor predicts mortality in patients with systemic inflammatory response syndrome.
Raggam RB; Wagner J; Prüller F; Grisold A; Leitner E; Zollner-Schwetz I; Valentin T; Krause R; Hoenigl M
J Intern Med; 2014 Dec; 276(6):651-8. PubMed ID: 24645798
[TBL] [Abstract][Full Text] [Related]
7. Soluble urokinase-type plasminogen activator receptor is a novel biomarker predicting acute exacerbation in COPD.
Gumus A; Altintas N; Cinarka H; Kirbas A; Hazıroglu M; Karatas M; Sahin U
Int J Chron Obstruct Pulmon Dis; 2015; 10():357-65. PubMed ID: 25709430
[TBL] [Abstract][Full Text] [Related]
8. Serum soluble urokinase-type plasminogen activator receptor as a serum marker of inflammatory response that leads to tissue damage and surgical complication.
Tognoli E; Luigi Giuseppe Leoni M; Morelli D; Sottotetti E; Martinetti A; Signoroni S; Galeone C; Gallino G
Wound Repair Regen; 2016 Nov; 24(6):1036-1040. PubMed ID: 27759946
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic and prognostic significance of suPAR in traumatic brain injury.
Yu L; Wu X; Wang H; Long D; Yang J; Zhang Y
Neurol India; 2014; 62(5):498-502. PubMed ID: 25387618
[TBL] [Abstract][Full Text] [Related]
10. Circulating soluble urokinase plasminogen activator is elevated in patients with chronic liver disease, discriminates stage and aetiology of cirrhosis and predicts prognosis.
Zimmermann HW; Koch A; Seidler S; Trautwein C; Tacke F
Liver Int; 2012 Mar; 32(3):500-9. PubMed ID: 22098627
[TBL] [Abstract][Full Text] [Related]
11. Plasma Level of Soluble Urokinase-type Plasminogen Activator Receptor Predicts the Severity of Acute Alcohol Pancreatitis.
Nikkola A; Aittoniemi J; Huttunen R; Rajala L; Nordback I; Sand J; Laukkarinen J
Pancreas; 2017 Jan; 46(1):77-82. PubMed ID: 27841794
[TBL] [Abstract][Full Text] [Related]
12. Soluble urokinase plasminogen activator receptor is compartmentally regulated in decompensated cirrhosis and indicates immune activation and short-term mortality.
Zimmermann HW; Reuken PA; Koch A; Bartneck M; Adams DH; Trautwein C; Stallmach A; Tacke F; Bruns T
J Intern Med; 2013 Jul; 274(1):86-100. PubMed ID: 23432143
[TBL] [Abstract][Full Text] [Related]
13. Plasma suPAR as a prognostic biological marker for ICU mortality in ARDS patients.
Geboers DG; de Beer FM; Tuip-de Boer AM; van der Poll T; Horn J; Cremer OL; Bonten MJ; Ong DS; Schultz MJ; Bos LD
Intensive Care Med; 2015 Jul; 41(7):1281-90. PubMed ID: 26100127
[TBL] [Abstract][Full Text] [Related]
14. Soluble urokinase-type plasminogen activator levels are related to plasma cytokine levels but have low predictive value for mortality in trauma patients.
Timmermans K; Vaneker M; Scheffer GJ; Maassen P; Janssen S; Kox M; Pickkers P
J Crit Care; 2015 Jun; 30(3):476-80. PubMed ID: 25721031
[TBL] [Abstract][Full Text] [Related]
15. Plasma soluble urokinase-type plasminogen activator receptor level is independently associated with coronary microvascular function in patients with non-obstructive coronary artery disease.
Mekonnen G; Corban MT; Hung OY; Eshtehardi P; Eapen DJ; Al-Kassem H; Rasoul-Arzrumly E; Gogas BD; McDaniel MC; Pielak T; Thorball CW; Sperling L; Quyyumi AA; Samady H
Atherosclerosis; 2015 Mar; 239(1):55-60. PubMed ID: 25574858
[TBL] [Abstract][Full Text] [Related]
16. Cerebral Oximetry as a Real-Time Monitoring Tool to Assess Quality of In-Hospital Cardiopulmonary Resuscitation and Post Cardiac Arrest Care.
Ibrahim AW; Trammell AR; Austin H; Barbour K; Onuorah E; House D; Miller HL; Tutt C; Combs D; Phillips R; Dickert NW; Zafari AM
J Am Heart Assoc; 2015 Aug; 4(8):e001859. PubMed ID: 26307569
[TBL] [Abstract][Full Text] [Related]
17. Soluble urokinase plasminogen activator receptor associates with higher risk, advanced disease severity as well as inflammation, and might serve as a prognostic biomarker of severe acute pancreatitis.
Zhang Q; Li L; Chen H; Zhang G; Zhu S; Kong R; Chen H; Wang G; Sun B
J Clin Lab Anal; 2020 Mar; 34(3):e23097. PubMed ID: 31774228
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of suPAR and hs-CRP on cardiovascular disease.
Diederichsen MZ; Diederichsen SZ; Mickley H; Steffensen FH; Lambrechtsen J; Sand NPR; Christensen KL; Olsen MH; Diederichsen A; Grønhøj MH
Atherosclerosis; 2018 Apr; 271():245-251. PubMed ID: 29402404
[TBL] [Abstract][Full Text] [Related]
19. Soluble Urokinase Plasminogen Activator Receptor: A New Biomarker in the Pediatric Intensive Care Unit.
El-Mekkawy MS; Saleh NY; Sonbol AA
Indian J Pediatr; 2016 Jul; 83(7):661-9. PubMed ID: 26960717
[TBL] [Abstract][Full Text] [Related]
20. The Prognostic Significance of Soluble Urokinase Plasminogen Activator Receptor in Acute Myeloid Leukemia.
Erkut N; Menteşe A; Özbaş HM; Ermantaş N; Sümer A; Örem A; Sönmez M
Turk J Haematol; 2016 Jun; 33(2):135-40. PubMed ID: 26376588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]